Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One“) applauds a recent survey study published in the European Journal of Pain, which suggests that psychedelic substances could offer potential therapeutic value in addressing specific chronic pain conditions. By conducting an extensive survey among 170 individuals dealing with chronic pain and who met…

Core One Labs Inc. (CSE:COOL | OTCQB:CLABF | Frankfurt:LD6 | WKN: A3CSSU), is pleased to announce that it has acquired GMP Drug Inc., an arms-length privately held company that operates through a Good Manufacturing Practices facility owned by a third-party located in Ontario, Canada. The Acquisition will lay the path for the Company to become a…

Core One Labs Inc. (CSE: COOL | OTCQB: CLABF | Frankfurt: LD6, WKN: A3CSSU) the Company is pleased to announce that its wholly-owned subsidiary, Vocan Biotechnologies Inc., has successfully achieved two critical development milestones, the successful synthesis of psilocybin and the filing of a patent application for the process with the United States Patent and Trademark Office. Achievement of…

Core One Labs Inc. (CSE: COOL | OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) – Further to its news release dated September 29, 2022, the Company is pleased to announce the appointment BF Borgers CPA PC (‘BF Borgers’ or the ‘Successor Auditor’) as its new auditor effective as of November 23, 2022. BF Borgers replaces Dale Matheson Carr-Hilton Labonte LLP (‘DMCL’…